what is the fda deadline for glp-1 drugs π¨ Moves to Permanently Shut Down Compounded GLP-1s FDA taking steps to eliminate large-scale compounding of medications like semaglutide and tirzepatide, signaling a major shift in how these Former FDA commissioner: GLP-1 drugs
Description
Learn about the Zepbound blindness lawsuit, including NAION and other eye side effects, and read about a study linking GLP-1 RAs to severe vision problems.

This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes
Society guidelines have left clinicians with some questionable recommendations
As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)
By Michael S

Check our Semaglutide weight loss dosage chart to find the right dose for safe and effective weight management
